SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct. 25, 2005--Hana Biosciences Inc. (AMEX: HBX), a South San Francisco-based biopharmaceutical company focused on advancing cancer care, announced today that it has completed its previously announced private placement. The company had previously announced on Oct. 19, 2005, that it had entered into a definitive agreement relating to the private placement.
